During the past decade, Florida Wellcare Alliance conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Florida Wellcare Alliance" are "Osteoporosis" (2 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Esophagitis" (1 trials), "Lung Cancer" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Florida Wellcare Alliance" in a lesser frequency.

Most popular intervention types in "Florida Wellcare Alliance" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (2 trials), "ALX1-11" (1 trials), "ALX1-11 (drug)" (1 trials), "Amifostine" (1 trials) and "Doxorubicin HCl Liposome Injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Florida Wellcare Alliance" are 4 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Florida Wellcare Alliance". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Florida Wellcare Alliance, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Florida Wellcare Alliance, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".